Efficacy of IL-23 inhibitors and IL-12/23 inhibitors in the induction treatment of Crohn’s disease: A meta-analysis based on randomized controlled trials
Main Authors: | Boyang Gao, Haojie Shentu, Suyong Sha, Dongying Wang, Xi Chen, Zhenwei Huang, Nan Dong, Haijia Lai, Jianying Xu, Xiaoshuai Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2024-01-01
|
Series: | Central European Journal of Immunology |
Subjects: | |
Online Access: | https://www.termedia.pl/Efficacy-of-IL-23-inhibitors-and-IL-12-23-inhibitors-in-the-induction-treatment-of-Crohn-s-disease-A-meta-analysis-based-on-randomized-controlled-trials,10,52222,1,1.html |
Similar Items
-
The Role of IL-23 Inhibitors in Crohn’s Disease
by: Jacopo Fanizza, et al.
Published: (2023-12-01) -
No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors
by: Hua Zhang, et al.
Published: (2022-02-01) -
Crohn’s disease exacerbated by IL-17 inhibitors in patients with psoriasis: a case report
by: Jingyi Ju, et al.
Published: (2020-10-01) -
IL-23 Inhibitors for Moderate-to-Severe Plaque Psoriasis: A Review of Clinical Efficacy, Safety, and Tolerability
by: Sima D. Amin, et al.
Published: (2019-11-01) -
Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience
by: Silvia Giordano, et al.
Published: (2023-12-01)